Literature DB >> 29229597

Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma.

Yimeng Zhang1, Ting Wang1, Shan Wang1, Yanlu Xiong2, Rui Zhang1, Xiang Zhang1, Jing Zhao1, An-Gang Yang3, Lei Wang4, Lintao Jia4.   

Abstract

Aberrant Hedgehog signaling and excessive activation of the Gli family of transcriptional activators are key drivers of medulloblastoma (MB), the most common human pediatric brain malignancy. MB originates mainly from cerebellar granule neuron progenitors (CGNP), but the mechanisms underlying CGNP transformation remain largely obscure. In this study, we found that suppression of the noncoding RNA Nkx2-2as promoted Sonic Hedgehog (Shh)-potentiated MB development. Nkx2-2as functioned as a competing endogenous RNA against miR-103 and miR-107, sequestering them and thereby derepressing their tumor suppressive targets BTG2 and LATS1 and impeding cell division and migration. We also found that Nkx2-2as tethered miR-548m and abrogated its LATS2 targeting activity. Shh signaling impaired Nkx2-2as expression by upregulating the transcriptional repressor FoxD1. In clinical specimens of Shh-subgroup MB, we validated coordinated expression of the aforementioned proteins. Notably, exogenous expression of Nkx2-2as suppressed tumorigenesis and prolonged animal survival in MB mouse models. Our findings illuminate the role of noncoding RNAs in Hedgehog signaling and MB occurrence, with implications for identifying candidate therapeutic targets for MB treatment.Significance: These findings illuminate the role of noncoding RNAs in Hedgehog signaling and an interplay between the Hedgehog and Hippo pathways in medulloblastoma pathogenesis. Cancer Res; 78(4); 962-73. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29229597     DOI: 10.1158/0008-5472.CAN-17-1631

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  The multisystemic functions of FOXD1 in development and disease.

Authors:  Paula Quintero-Ronderos; Paul Laissue
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

Review 2.  The crosstalk between long non-coding RNAs and the hedgehog signaling pathway in cancer.

Authors:  Marzieh Lotfian Sargazi; Saeideh Jafarinejad-Farsangi; Maryam Moazzam-Jazi; Farzaneh Rostamzadeh; Zahra Miri Karam
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

3.  The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas.

Authors:  Keisuke Katsushima; Bongyong Lee; Haritha Kunhiraman; Cuncong Zhong; Rabi Murad; Jun Yin; Ben Liu; Alexandra Garancher; Ignacio Gonzalez-Gomez; Hector L Monforte; Stacie Stapleton; Rajeev Vibhakar; Chetan Bettegowda; Robert J Wechsler-Reya; George Jallo; Eric Raabe; Charles G Eberhart; Ranjan J Perera
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

Review 4.  The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma.

Authors:  Piyush Joshi; Keisuke Katsushima; Rui Zhou; Avner Meoded; Stacie Stapleton; George Jallo; Eric Raabe; Charles G Eberhart; Ranjan J Perera
Journal:  Neurooncol Adv       Date:  2019-09-06

Review 5.  The Non-coding Side of Medulloblastoma.

Authors:  Pietro Laneve; Elisa Caffarelli
Journal:  Front Cell Dev Biol       Date:  2020-05-27

Review 6.  Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer.

Authors:  Mengwei Wang; Tianwei Xu; Wenyan Feng; Junxia Liu; Zhaoxia Wang
Journal:  Onco Targets Ther       Date:  2021-04-07       Impact factor: 4.147

7.  Circulating Exosomal MiR-107 Restrains Tumorigenesis in Diffuse Large B-Cell Lymphoma by Targeting 14-3-3η.

Authors:  Jiarui Liu; Yang Han; Shunfeng Hu; Yiqing Cai; Juan Yang; Shuai Ren; Yi Zhao; Tiange Lu; Xiangxiang Zhou; Xin Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-27

Review 8.  Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.

Authors:  Agata Strejczek; Dawid Woszczyk; Helena Urbaniak; Martyna Różańska; Michał Robak; Zofia Matuszewska; Anna-Maria Barciszewska
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

Review 9.  Non-coding RNAs in Brain Tumors, the Contribution of lncRNAs, circRNAs, and snoRNAs to Cancer Development-Their Diagnostic and Therapeutic Potential.

Authors:  Julia Latowska; Adriana Grabowska; Żaneta Zarębska; Konrad Kuczyński; Bogna Kuczyńska; Katarzyna Rolle
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

Review 10.  The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.

Authors:  Chao Tu; Kexin Yang; Lu Wan; Jieyu He; Lin Qi; Wanchun Wang; Qiong Lu; Zhihong Li
Journal:  Cell Prolif       Date:  2020-08-10       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.